(Q48786872)

English

Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy.

scientific article published on 21 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

author name string

Juliane Brandt

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

Sascha Dietrich

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

Julia Meissner

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

Kai Neben

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

Anthony D Ho

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

Mathias Witzens-Harig

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

publication date

21 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

51

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

11

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

2012-2020

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Managing relapsed and refractory Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Individual quality of life in long-term survivors of Hodgkin's lymphoma--a comparative study.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Fatigue in long-term survivors of Hodgkin‘s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG)

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Fatigue in long-term Hodgkin's Disease survivors: a follow-up study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Quality of life immediately after peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Better quality of life among 10-15 year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: a population-based study.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Quality of life in long-term Hodgkin's disease survivors with chronic fatigue.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Quality of life in survivors of Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

What concepts does the EQ-5D measure? Intentions and interpretations

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.513749

21 January 2018

Identifiers

10.3109/10428194.2010.513749

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858092

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48786872&oldid=1521016527"